Rudick, R A <br/><br/>
In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.  [electronic resource] 

 -  Neurology  Oct 1993 
 - 2080-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-3878 
<br/><br/><label>Standard No.: </label>10.1212/wnl.43.10.2080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Antigens, CD--biosynthesis<br/>Antigens, Differentiation, T-Lymphocyte--biosynthesis<br/>CD2 Antigens<br/>Cells, Cultured<br/>Humans<br/>Interferon-beta--pharmacology<br/>Interferon-gamma--pharmacology<br/>Kinetics<br/>Lymphocyte Activation--drug effects<br/>Mitogens<br/>Multiple Sclerosis--blood<br/>Receptors, Immunologic--biosynthesis<br/>Receptors, Interleukin-2--biosynthesis<br/>Receptors, Transferrin--biosynthesis<br/>Recombinant Proteins--pharmacology<br/>Reference Values<br/>T-Lymphocyte Subsets--drug effects<br/>T-Lymphocytes--drug effects<br/>Time Factors